当前位置: 首页 >> 检索结果
共有 38475 条符合本次的查询结果, 用时 8.5350723 秒

181. Response.

作者: Barbara Christine Weckler.;Bernd Schmeck.
来源: Chest. 2025年168卷1期e15-e16页

182. Sudden Right Lower Limb Paralysis: An Uncommon Presentation of Type A Aortic Dissection.

作者: Xiangxin Wang.;Zhuoqi Li.
来源: Chest. 2025年168卷1期e1-e2页
Acute aortic dissection is a rare and life-threatening emergency, with fatal outcomes often resulting from delayed or missed diagnoses. Type A aortic dissection, which typically presents with acute chest pain radiating to the back, is the most common cause of death associated with aortic lesions and requires urgent surgical intervention. We present an unusual case of type A aortic dissection that manifested solely with sudden paralysis and tingling of the right lower limb, without chest or back pain. Despite timely diagnosis in the emergency department, emergency surgical intervention failed to save the patient's life.

183. Pursuing Precision for a Persistent Issue in the Diagnosis of Neuroendocrine Cell Hyperplasia of Infancy.

作者: Telford Yeung.;Israel Amirav.
来源: Chest. 2025年168卷1期8-9页

184. Gender Inequities in Academic Medicine: Peer Review and Beyond.

作者: Rachel Kohn.;Meeta Prasad Kerlin.
来源: Chest. 2025年168卷1期6-7页

185. To Leak, or Not to Leak: Is That Really the Question?

作者: Dan Perri.;Thomas Piraino.
来源: Chest. 2025年168卷1期4-5页

186. Cardiopulmonary Imaging With 0.55T MRI.

作者: Felicia Seemann.;Adrienne E Campbell-Washburn.
来源: Chest. 2025年168卷1期16-18页

187. Measuring Activity in Pediatric Pulmonary Hypertension: Expanding Opportunities to Advance Clinical Trial Design and Impact.

作者: Eric D Austin.
来源: Chest. 2025年168卷1期13-15页

188. When Heartburn Meets Heart Failure: H2 Antagonism in Pulmonary Arterial Hypertension as a Potential Right Ventricular Remedy.

作者: Leo Godzecki.;Mardi Gomberg-Maitland.
来源: Chest. 2025年168卷1期10-12页

189. Low-Tidal-Volume Ventilation and Mortality in Patients With Acute Brain Injury: A Secondary Analysis of an International Observational Study.

作者: Julian F Daza.;Doulia M Hamad.;Martin Urner.;Kuan Liu.;Sarah Wahlster.;Chiara Robba.;Robert D Stevens.;Victoria A McCredie.;Raphael Cinotti.;Shaurya Taran.; .; .; .; .; .; .
来源: Chest. 2025年
Low-tidal-volume ventilation (LTVV) improves outcomes in critically ill patients, but its impact in patients with acute brain injuries (ABIs) is less certain.

190. The Influence of Hospital Policies on Clinicians' Decisions to Withhold or Withdraw Life-Sustaining Treatment.

作者: Gina M Piscitello.;Edlyn Lopez Wolwowicz.;Michael T Huber.;Kelly C Vranas.;Donald R Sullivan.;Katrina E Hauschildt.;Patrick G Lyons.
来源: Chest. 2025年
There is considerable variation in clinicians' approaches to decisions to withhold or withdraw life-sustaining treatment (LST) across US hospitals. These differences are not explained by patient preferences alone and are likely influenced by other factors (eg, hospital policies, hospital culture, state laws, medical society guidelines).

191. The Impact of the Unknown: Patient Experiences With Uncertainty in Sarcoidosis.

作者: Kristen R Mathias.;Michelle N Eakin.;Katrina E Hauschildt.;Edward S Chen.;Nisha A Gilotra.;Nancy W Lin.;Catherine A Bonham.;Michelle Sharp.
来源: Chest. 2025年
Individuals with sarcoidosis face many sources of illness uncertainty, including diagnostic delays, unpredictable therapeutic efficacy and toxicity, and disease-associated morbidity and mortality. Patient perspectives on illness uncertainty in sarcoidosis have not been evaluated critically and offer an opportunity for providers to contextualize and prioritize gaps in care and patient support.

192. Beryllium Lymphocyte Proliferation Test: Differential Diagnosis of Sarcoidosis and Chronic Beryllium Disease.

作者: Louis Jouanjan.;Charlott Terschluse.;Gernot Zissel.;Prerana Agarwal.;Emil Wachenfeld.;Caroline Quartucci.;Daniel Soriano.;Joachim Müller-Quernheim.;Daiana Stolz.;Björn C Frye.
来源: Chest. 2025年
Chronic beryllium disease (CBD) is considered a phenocopy of sarcoidosis, generally caused by occupational exposure to beryllium. Its diagnosis relies on the demonstration of beryllium sensitization by the beryllium lymphocyte proliferation test (BeLPT).

193. Segmentectomy vs Lobectomy for Patients With 2- to 3-cm Non-Small Cell Lung Cancer.

作者: Camille A Mathey-Andrews.;Alexandra L Potter.;Deepti Srinivasan.;Priyanka Senthil.;Hiba Elkhatib.;Danny Wang.;Arvind Kumar.;Michael Lanuti.;Lana Schumacher.;Chi-Fu Jeffrey Yang.
来源: Chest. 2025年
Two studies recently demonstrated the noninferiority of sublobar resection to lobectomy in patients with T1a-bN0M0 non-small cell lung cancer (NSCLC). However, whether segmentectomy is associated with similar oncologic outcomes to lobectomy for patients with node-negative T1c tumors (ie, those 2-3 cm) remains unknown.

194. Incidence of Discordant Pleural Fluid Exudates and Diagnostic Patterns: A Retrospective Cohort Study.

作者: Dinesh N Addala.;Rachel Mercer.;Anand Sundaralingam.;Beenish Iqbal.;Alguili Elsheikh.;Eihab O Bedawi.;John Wrightson.;Robert J Hallifax.;Najib M Rahman.
来源: Chest. 2025年
Light's criteria use pleural fluid protein and lactate dehydrogenase (LDH) to differentiate pleural effusions as exudative or transudative. In a subset of exudative pleural effusions, discordance occurs between LDH and protein (ie, protein high, LDH low, or vice versa).

195. Airway Mucus Plugging in Chronic Bronchitis and the Impact of Bronchial Rheoplasty.

作者: William S Krimsky.;Joseph G Mammarappallil.;Victor Kim.;Brett Bannan.;Jean-Paul Charbonnier.;Beryl A Hatton.;Frank C Sciurba.
来源: Chest. 2025年
Chronic bronchitis (CB) is characterized by excessive airway mucus production. Mucus plugs occluding the airway are common in CB, are associated with increased all-cause mortality, and can be identified on CT imaging.

196. Management of Patients With Early-Stage Non-Small Cell Lung Cancer: An American College of Chest Physicians Clinical Practice Guideline.

作者: John Howington.;Lesley H Souter.;Douglas Arenberg.;Justin Blasberg.;Frank Detterbeck.;Farhood Farjah.;Michael Lanuti.;Natasha Leighl.;Gregory M Videtic.;Sudish Murthy.
来源: Chest. 2025年168卷3期810-827页
Lung cancer remains the number 1 cause of cancer death in men and women in the United States and much of the world. This CHEST organization guideline examines the literature on primary treatment of patients with stage I and II non-small cell lung cancer (NSCLC) to provide evidence-based recommendations.

197. Delivering a Regional Procedural Bootcamp for Incoming Pulmonary and Critical Care Medicine Fellows.

作者: Saadia A Faiz.;Mark T Warner.;Donald R Lazarus.;Philip Ong.;Kevin C Proud.;Kha Dinh.;Lilit A Sargsyan.;Juan F Sanchez.;Maya I Hoffman.;Mohammad F Zaidan.;Ramsy Abdelghani.;Philip Alapat.;Katherine Richards.;Sami Bashour.;Nikhil Meena.;Robert J Walter.;Ebtesam Islam.;Shawn P Nishi.;Catherine N Vu.;William F Kelly.;Georgie A Eapen.
来源: Chest. 2025年
Successful procedural training is a universal concern for pulmonary and critical care medicine (PCCM) program directors. Bootcamps may provide a unique and often first opportunity for intense, immersive procedural learning without exposing patients to harm. New trainees must otherwise learn on the job while acclimating to unfamiliar environments and responsibilities. Our goal was to create a structured regional educational event conducted early in fellowship. We aspired to optimize familiarity with procedures and equipment, allay stress among trainees, and create a collaborative learning environment through sharing of simulation equipment and faculty among programs. This article outlines the design, implementation, and lessons learned from this 1-day, multidisciplinary PCCM and critical care medicine procedural bootcamp in the southwest region of the United States. The bootcamp program was designed as learner centered, with educational and experiential goals and feasibility in mind, using a flipped classroom model and testing to maximize time for psychomotor skills building. A multidisciplinary approach enriched the learning environment, modeled team-based procedural care, and fostered interprofessional collaboration. Assessments measured pre-knowledge and post-knowledge acquisition as well as gauged learner performance using checklists and small group interaction. Evaluation of feedback from learners, faculty, and participating programs allowed for yearly iterative improvements. We share these lessons learned as a model for other scalable and impactful medical education initiatives.

198. Excellence for All: Simulation-Based Mastery Learning for ICU Goals of Care Conversations.

作者: Melanie M Smith.;James M Walter.;Natalie K Munger.;Elaine R Cohen.;Julia H Vermylen.;Gordon J Wood.
来源: Chest. 2025年

199. Anomalous Differences Between the Global Lung Function Initiative 2023 and 2012 Spirometry Reference Values.

作者: Brian L Graham.;Veronica Marcoux.;Yet H Khor.;Allan L Coates.
来源: Chest. 2025年
In 2012, the Global Lung Function Initiative (GLI) collected a large international database of spirometry measurements in healthy people from which predicted spirometric values were derived based on sex, age, and height for people from 4 different geographic ancestral groups. In 2023, a single set of predicted spirometry values was developed for the entire data set, designed to be independent of ancestry.

200. Components Necessary for High-Quality Lung Cancer Screening: A 10-Year Update.

作者: Julie A Barta.;Douglas Arenberg.;Leah Backhus.;Frank Detterbeck.;Michael K Gould.;Viswam S Nair.;Mary Pasquinelli.;Charles A Powell.;Kim Sandler.;Gerard Silvestri.;Matthew Triplette.;Anil Vachani.;Renda S Wiener.;Peter J Mazzone.
来源: Chest. 2025年
Lung cancer screening (LCS) has evolved over the past decade with research advances and clinical experience helping to define target populations for screening, improve lung nodule detection and management, and identify structural components of programs that improve the quality of screening delivery. The 2015 American College of Chest Physicians and American Thoracic Society policy statement "Components Necessary for High-Quality Lung Cancer Screening" identified 9 essential components for high-quality LCS. Ten years later, optimizing the balance between the benefits and harms of LCS and ensuring equitable screening among all population groups remain fundamental objectives. In this 2025 update, we aimed to summarize new knowledge and highlight critical components that are needed for providing high-quality LCS. A multidisciplinary group of LCS experts was assembled to review evidence from the past 10 years. The original components were reviewed and updated to develop 8 refined components that should be considered essential structural elements of screening programs. Each component recommended by the authors is supported by an evidence update. Applying this framework will allow screening programs across the country to ensure implementation of high-quality, net-benefit LCS.
共有 38475 条符合本次的查询结果, 用时 8.5350723 秒